Organization

NYC Health + Hospitals/Jacobi

1 abstract

Abstract
Response and outcomes with immune checkpoint inhibitor (ICI) in patients (pts) with urothelial carcinoma (UC) and subtype histology (SH).
Org: NYC Health + Hospitals/Jacobi, Attiko Hospital, Marqués de Valdecilla Universitary Hospital,